1. Protective role of diosmin against testosterone propionate-induced prostatic hyperplasia in Wistar rats: Plausible role of oxidative stress and inflammation
   A Vafa et al, 2020, Human & Experimental Toxicology CrossRef
2. Simvastatin ameliorates testosterone-induced prostatic hyperplasia in rats via modulating IGF-1/PI3K/AKT/FOXO signaling
   Nyera H. El-Shafei et al, 2023, European Journal of Pharmacology CrossRef
3. Psoralea corylifolia L. extract ameliorates benign prostatic hyperplasia by regulating prostate cell proliferation and apoptosis
   Hyo-Jung Kim et al, 2021, Journal of Ethnopharmacology CrossRef
4. Canagliflozin alleviates experimentally induced benign prostate hyperplasia in a rat model: exploring potential mechanisms involving mir-128b/EGFR/EGF and JAK2/STAT3 signaling pathways through in silico and in vivo investigations
   Eman M. Elbaz et al, 2023, European Journal of Pharmacology CrossRef
5. Amelioration of Benign Prostatic Hyperplasia by Costunolide and Dehydrocostus Lactone in Wistar Rats
   Dohyun Choi et al, 2021, The World Journal of Men's Health CrossRef
6. Diacerein ameliorates testosterone-induced benign prostatic hyperplasia in rats: Effect on oxidative stress, inflammation and apoptosis
   Mohamed El-Sherbiny et al, 2021, International Immunopharmacology CrossRef